China Association for the promotion of drugs held a meeting on contacting secretaries of member units in 2013

Source: China pharmaceutical promotion association 2013-09-09 in order to hold the fourth session of the ninth general meeting and 2013 International Pharmaceutical Innovation Summit Forum, on September 6, 2013, China Pharmaceutical Industry Research and Development Promotion Association (hereinafter referred to as China pharmaceutical promotion association) held the 2013 liaison Secretary meeting of member units in Chifeng City, Inner Mongolia Nearly 40 contact secretaries and specially invited experts from more than 30 member units of China Pharmaceutical Association attended the meeting Song Ruilin, executive chairman of China pharmaceutical promotion association, made a report on "opportunities and challenges brought by current hot issues to enterprises" Feng LAN, Deputy Secretary General of China pharmaceutical promotion association presided over the meeting The meeting first heard the "2012 work report of the association and recent key work report" by Chen Changxiong, Executive Deputy Secretary General of the China Association for the promotion of drugs The report summarizes a series of work carried out by China pharmaceutical promotion association in 2012 around the tenet of "innovation, industrialization and internationalization", in order to meet the future development needs of China's pharmaceutical industry from a global perspective, the focus of the work of the association has been adjusted to serve the innovation of the pharmaceutical industry In order to improve the working efficiency of the association, we are strengthening the Association At the same time of system construction, in order to mobilize the enthusiasm of the members, we should reform the organizational structure of the association in accordance with the principle of democratic organization of the association, take the lead in implementing the rotating chairman system, and strictly enforce the membership review system, so as to make China pharmaceutical promotion Association step forward to the international and modern industry association organization greatly, and obtain the full affirmation of the relevant leading departments In order to improve the construction of new drug market environment, China Council for the promotion of drugs, together with China Pharmaceutical University and China Pharmaceutical Association, initiated the establishment of "National Center for drug policy and Economic Research of pharmaceutical industry" by setting up related policy research topics To organize research on pilot medical insurance units, hold seminars on hot issues and enterprise symposiums, and submit research results reports and relevant policy suggestions to relevant management departments, so as to build a platform for in-depth exchanges between the government and enterprises As the first association to propose amendments to the draft of drug trading rules of the Department of health of Guangdong Province, CCPIT is also the only one to propose amendments to the medical treatment in Shanghai The association that provides written opinions on the implementation plan of "purchasing with quantity" of the insurance office; in order to fully elaborate the opinions of the association, song Ruilin, executive chairman, also made a special trip to Shanghai to fully communicate with the relevant leaders of Shanghai Social Security Bureau, and finally Shanghai Medical Insurance Office accepted the opinions and suggestions of the association Meanwhile, 2012 The annual China pharmaceutical promotion association increased the frequency and depth of international exchanges, organized many entrepreneur delegations to Denmark, Switzerland, Poland, the United States, Canada and other places for project cooperation investigation; organized large-scale medical directors of Beijing to attend senior management training in Sydney University Hospital; carried out cross-strait exchanges, sent personnel to Taiwan for the first time to attend the biotechnology industry conference, and worked with Taiwan Biotechnology The association established contacts to promote win-win cooperation in cross strait pharmaceutical industry; strengthened contacts and cooperation with embassies in China, and established contacts with embassies of India and Poland in China; jointly held "2012 International Pharmaceutical Innovation Summit" with rdpac of China Association of foreign funded enterprises and pharma of the United States Through business investigation in Europe, America and other countries, at present, there are three member enterprises of CCPIT and foreign research institutions that have established product or project cooperation The report also gives a brief report on the "Ninth fourth general meeting" and "preparations for the 2013 International Pharmaceutical Innovation Summit" to be held in Beijing in October 2013 Song Ruilin, executive chairman of China Association for the promotion of drugs, presided over the discussion on the key work of 2014 and made a special report on "opportunities and challenges brought by current hot issues to enterprises" The report points out that due to historical reasons, there are some misunderstandings in China's pharmaceutical industry, such as: the quality of the original drugs must be higher than that of the generic drugs, which lead to the deviation of some current pharmaceutical policies, including the wrong understanding of the quality of drugs in the drug purchase and bidding policies Through the research and comparison of foreign drug management policies, the report puts forward measures to solve major policy problems in the pharmaceutical industry, such as drug pricing, drug bidding and purchase, drug evaluation and drug application involving patent issues, which are in line with the development law of the Chinese pharmaceutical market from a new perspective, and provides reference for the establishment of pharmaceutical management policies in line with the law of the market economy Zhang Qingkui made a report on "intellectual property protection and enterprise innovation" In order to popularize the knowledge of pharmaceutical intellectual property and enhance the patent awareness of member units, Zhang Qingkui, the former director of the examination department of pharmaceutical biological invention of the Patent Office of the State Intellectual Property Office, was specially invited to make a special report on "intellectual property protection and enterprise innovation" Song Ruilin, executive chairman of CFDA, pointed out that the core of CFDA's work is to promote innovation, create a good external environment for innovation, and firmly serve the industrial development and the legitimate interests of member enterprises Thank you for your great support to our association all the way It is hoped that the majority of member units and China Pharmaceutical Council will work together to promote the innovation and development of China's pharmaceutical industry China Association for the promotion of drugs will strive to create conditions for members to build a higher and deeper multi field exchange platform Meeting place for liaison Secretary